MAPT and Parkinson disease: It is also pivotal to employ novel transcriptomic techniques to explore ferroptosis-related pathways at a molecular level with inclusions and without inclusions, to understand the role of aS/tau in driving ferroptosis changes at the genome level, and to bridge the knowledge gaps in the function of specific markers in order to deepen our understanding of parkinsonism pathophysiology.